News and Comments

Onyx (ONXX) Was Right All Along

  Monday, July 26, 2010

In October 2009, Onyx (ONXX) paid $276 million up front to acquire the privately held Proteolix to get to its multiple myeloma drug carfilzomib. It promised $535 million in future payments largely contingent on carfilzomib's approval. As usual, investors did not like Onyx paying money, because investors do not like any company to pay money to develop or acquire state-of-the- art products. When somebody hates something he sees everything in it with pessimism. Onyx put its hands on carfilzomib, which looked very promising for multiple myeloma cases resistant to current treatments. The breakthrough multiple myeloma drugs Velcade (bortezomib) and Revlimid (lenolidamide) could not prevent the cancer from recurring and failed to work at all on a large percentage of recurrent cancer.  More...


Recent Postings


Archive


Tags

Micromet (MITI) AGOS (ARGS) Dynavax (DVAX) OSI (OSIP) Dendreon (DNDN) galapagos (GLPG) ImmunoGen (IMGN) ADVENTRIX (ANX) Sanofi-Aventis (SAN) Illumina (ILMN) Tysabri GUARDIAN HEALTH PTC Therapeutics (PTCT) RenenxBio (RGNX) SERES THERAPEUTICS (MCRB) Genentech Aimmune Therapeutics (AIMT) Multiple Myeloma Advaxis (ADXS) Sequenom (SQNM) Ocular Therapeutix (OCUL) Mirati Therapeutics (MRTX) Intrexon (XON) Velcade (bortezomib) HALOZYME (HALO) Theravance Bio Pharma (TBPH) Idenix (IDIX) NEKTAR (NKTR)) Pluristem (PSTI) ARCA (ABIO) Onyx (ONXX) Prosensa (RNA) Cytokinetics (CYTK) Roche (ROCHE) GlaxoSmithKline (GSK) REGULUS (RGLS) Human Longevity (HLI) Ariad (ARIA) Sarepta (SRPT) Elan (ELN) Spike Therapeutics (ONCE) Anacor (ANAC) PORTOLA (PTLA) Galena (GALE) Adaptimmune (ADAP) CRISPR Therapeutics (CRSP) Sangamo (SGMO) Sanofi (SNY) Editas (EDIT) ARGOS (ARGS) Trastuzumab-DM1 Agenus (AGEN INNOVIVA (INVA) Bristol-Myers Squibb (BMY) Intermune (ITMN) Vitae Pharmaceuticals (VTAE) Rapamune NANTKWEST (NK) C4 Therapeutics Agenus (AGEN) Bellicum (BLCM) KERYX (KERX) BIOMARIN (BMRN) Intercept (ICPT) Revlimid (lenolidamide) Zerenex Human Genome Sciences (HGSI) Alder Biopharmaceuticals (ALDR) Amgen (AMGN) AstraZeneca (AZN) AERIE PHARMACEUTICALS Incyte (INCY) Sanofi (SNA) Endometrial Cancer ACADIA (ACAD) Telaprevir Gilead (GILD) Ziofpharm (ZIOP) Abbott Laboratories (ABT) ZALTRAP™ Herceptin Anadys (ANDS) SUNESIS PHARMACEUTICALS (SNSS) Biocryst (BCRX) Global Cell Therapeutics (GBT) Merck (MRK) Alnylam (ALNY) Inovio (INO) JUNO (JUNO) Ridaforolimus Biogen Idec (BIIB) Seattle Genetics (SGEN) Ionis (IONS) Jazz Pharmaceuticals (JAZZ) ABBVIE (ABBV) ISIS (ISIS) CompuGen (CGEN) Auspex (ASPX) SYNTA (SNTA) NOVOCURE (NVCR) Array Pharmaceuticals (ARRY) IDERA (IDRA) Xoma (XOMA) Benlysta (belimumab) Regeneron (REGN) Vertex (VRTX) Exelixis (EXEL) Valeant Pharmaceuticals International (VRX) CEMPRA (CEMP) Prolor Biotech (PBTH) Theravance (THRX) KITE (KITE) Roche (RHHBY) TOKAI (TKAOI) MODERNA VANDA (VNDA)